Mumbai: Domestic pharma companies received more than 300 approvals in 2017 to launch generic drugs in the US, which is an all-time high. The clearances came despite regulatory pressure from the US Food and Drug Administration (FDA), and unprecedented warning letters issued to the pharma ...
Read more: Indian pharma cos get record 300 USFDA generic drug nods in 2017